EUCTR2014-000882-34-BEActive, not recruitingPhase 1
Catheter based adjuvant intraperitoneal chemotherapy for carcinomatosis.
niversity Hospital Ghent0 sites24 target enrollmentStarted: May 5, 2014Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •-Peritoneal carcinomatosis from GI origin (appendix, colon, small bowel, stomach)
- •-Resectable disease
- •-No or minimal systemic or extra-abdominal disease or metastatic spread
- •-Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 22
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 2
Exclusion Criteria
- •-Comorbidity that precludes surgery and/or IP chemotherapy
- •-Irresectable disease
Investigators
Similar Trials
Active, not recruiting
Phase 1
Preoperative intraperitoneal chemotherapy in adjuvant hyperthermiaadjunctive therapy in advanced gastric cancer with high-risk of peritoneal recurrence - a multicentre randomized trialGastric CarcinomaMedDRA version: 21.0Level: LLTClassification code 10007350Term: Carcinoma gastricSystem Organ Class: 100000004864EUCTR2020-001419-25-PLJagiellonian University Medical College600
Active, not recruiting
Not Applicable
Intraperitoneal hyperterm chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal origiAdjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosisthe COLOPEC randomized multicenter trialEUCTR2014-002794-11-NLAcademic Medical Center176
Completed
Phase 3
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicenter trial.metastases of peritoneumperitoneal carcinomatosis100179901002747610017998NL-OMON47140Academisch Medisch Centrum185
Not yet recruiting
Phase 2
Determining the efficacy and safety of neoadjuvant IP chemotherapy in rectal cancer patients with the spread of disease in peritoneumCTRI/2023/11/059575Tata Memorial Hospital
Active, not recruiting
Phase 1
Intraoperatieve intraperitoneale Chemoperfusie voor de behandeling van minimale residuele ziekte bij stadium III Eierstokkanker: een gerandomiseerde fase II studie.stage III ovarian cancerEUCTR2015-000418-23-BEGhent University Hospital60